BEIJING, Nov. 10, 2020 /PRNewswire/ — Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced t…
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
Huion Kamvas RDS-160: a Creative Pen Display to Empower Your Creativity
9D NFT Raised $2.9 Million – Ready For IDO
China-Singapore Trade in Services Innovation Forum to Discuss New Paths for High-Level Opening-Up
The Luxury Collection Announces Australian Debut with the Opening of The Tasman, a Luxury Collection Hotel, Hobart on 9 December 2021
